Leuprolide
Back to searchMolecule Structure
Scientific Name
Leuprolide
Description of the Drug
Leuprolide is a peptide-based GnRH receptor superagonist used for the palliative treatment of prostate cancer, uterine leiomyomata, endometriosis, and central precocious puberty.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00007
http://www.drugbank.ca/drugs/DB00007
Brand Name(s)
Not Available
Company Owner(s)
Ortho Mcneil Janssen Pharmaceutical Inc, Gp-Pharm Sa, Sandoz Inc, Teva Pharmaceuticals Usa, Tolmar International Ltd, Sun Pharmaceutical Industries Ltd, Foresee Pharmaceuticals Co Ltd, Abbvie Endocrine Inc, Tolmar Therapeutics Inc, Genzyme Corporation
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Gonadotropin-releasing hormone receptor | SINGLE PROTEIN | AGONIST | CHEMBL1855 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4585 | |||
| Human Metabolome Database | HMDB0041916 | |||
| WDI | LEUPROREL | |||
| DrugBank | DB00007 | |||
| PubChem: Thomson Pharma | 14890460 | 14841815 | 14939438 | 14939439 |
| PubChem | 657181 | |||
| Nikkaji | J34.477J | |||
| EPA CompTox Dashboard | DTXSID50872411 | |||
| DrugCentral | 1559 | |||
| ChemicalBook | CB8398455 | |||
| Guide to Pharmacology | 1175 | |||
| GSRS | 105f0ac9-a55c-4d1e-bdae-9f01145a039a | |||
| rxnorm | LUPRON | LEUPROLIDE | ELIGARD | LEUPROLIDE ACETATE |
| ChEBI | 6427 |
